Recent discussions on X about SINTX Technologies (SINT) have been buzzing with activity following the company's strategic acquisition of SiNAPTIC and its renewed focus on silicon nitride implants for medical devices. Many users on the platform are highlighting the potential growth from this move, pointing to the expansion of SINTX’s portfolio in orthopedic innovations as a key driver. The news of a director purchasing shares this week has also sparked interest, with some interpreting it as a signal of insider confidence.
Additionally, posts on X have noted the company’s advancements in hybrid trauma plates using silicon nitride, with several users expressing optimism about the technology’s potential to revolutionize bone healing. While the chatter includes speculation on price breakouts and upward momentum, there’s a mix of cautious voices questioning the sustainability of recent developments. The conversation remains dynamic as investors weigh the risks and rewards of SINTX’s latest moves.
Note: This discussion summary was generated from an AI condensation of post data.
SINTX Technologies Insider Trading Activity
SINTX Technologies insiders have traded $SINT stock on the open market 27 times in the past 6 months. Of those trades, 27 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SINT stock by insiders over the last 6 months:
- GREGG R. HONIGBLUM (Chief Investment Officer) has made 15 purchases buying 64,000 shares for an estimated $209,826 and 0 sales.
- ERIC K. OLSON (President and CEO) has made 9 purchases buying 24,975 shares for an estimated $65,557 and 0 sales.
- MARK LEWIS ANDERSON has made 2 purchases buying 15,000 shares for an estimated $44,800 and 0 sales.
- JAY M MOYES purchased 3,000 shares for an estimated $10,756
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SINTX Technologies Analyst Ratings
Wall Street analysts have issued reports on $SINT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 05/30/2025
To track analyst ratings and price targets for SINTX Technologies, check out Quiver Quantitative's $SINT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
